Stay updated with breaking news from Lipoprotein A. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Australia: Daily administration of Muvalaplin, a selective small molecule inhibitor of Lp(a) formation, for 14 days lowered Lipoprotein(a) levels up to 65% and was not associated with tolerability...
Netherlands: Lipoprotein(a) is robustly associated with the development of aortic valve calcification (AVC) but not with the progression of calcification over long-term follow-up, says a recent study....
Netherlands: Results from a pilot study published in the journal Atherosclerosis showed that in patients hospitalized with COVID-19, the levels of lipoprotein(a) increase threefold during...